Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 25Bayer AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi capsules

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67281

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi capsules

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67281

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi oral solution

Dosage Form : Oral Solution

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 28/05/2020

Application Number : 67282

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

larotrectinib

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

05

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

larotrectinib

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

06

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

larotrectinib

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date : 19-09-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

08

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date : 19-09-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

09

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 2000mg/100ml

Packaging :

Approval Date : 19-09-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 1000mg/50ml

Packaging :

Approval Date : 18-08-2021

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

11

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

LAROTRECTINIB (LAROTRECTINIB SULFATE)

Brand Name : VITRAKVI

Dosage Form : CAPSULE

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 2490315

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

12

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

LAROTRECTINIB (LAROTRECTINIB SULFATE)

Brand Name : VITRAKVI

Dosage Form : CAPSULE

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 2490323

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

13

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

LAROTRECTINIB (LAROTRECTINIB SULFATE)

Brand Name : VITRAKVI

Dosage Form : SOLUTION

Dosage Strength : 20MG/ML

Packaging :

Approval Date :

Application Number : 2490331

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

14

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

CPhI Japan
Not Confirmed
arrow
arrow
CPhI Japan
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank